Synthroid and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported as a side effect among people who take Synthroid (levothyroxine sodium), especially for people who are female, 60+ old, also take Cymbalta, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Acarodermatitis when taking Synthroid. It is created by eHealthMe based on reports of 237,758 people who have side effects when taking Synthroid from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,189 Synthroid users. Check the latest studies of Synthroid.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 245 drugs and 308 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

On Jan, 28, 2026

237,758 people reported to have side effects when taking Synthroid.
Among them, 18 people (0.01%) have Acarodermatitis.

Among these 18 people:

What is the gender of people who have Acarodermatitis when taking Synthroid? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Acarodermatitis when taking Synthroid? *

What are other drugs people take besides Synthroid? *

What are other side effects people have besides Acarodermatitis? *

Headache (pain in head): 8 people, 44.44%
Gums - Swollen: 4 people, 22.22%
Breast Infection: 4 people, 22.22%
Fatigue (feeling of tiredness): 4 people, 22.22%
Insomnia (sleeplessness): 4 people, 22.22%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 22.22%
Cough: 4 people, 22.22%
Chills (felling of cold): 4 people, 22.22%
High Blood Pressure: 3 people, 16.67%
Itching: 3 people, 16.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 33.33%
Abnormal Sleep-Related Event: 2 people, 11.11%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.11%
Stress And Anxiety: 2 people, 11.11%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 2 people, 11.11%
Bipolar Disorder (mood disorder): 2 people, 11.11%
Depression: 2 people, 11.11%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 11.11%
Hair Loss: 1 person, 5.56%
Arrhythmias (irregular heartbeat): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and have Acarodermatitis?

- Check whether Acarodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synthroid:

Synthroid (249,189 reports)

Acarodermatitis treatments and more:

Acarodermatitis (2,497 reports)

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acarodermatitis:

Acarodermatitis (245 drugs)

Browse all the conditions that are associated with Acarodermatitis:

Acarodermatitis (308 conditions)

Drugs similar to Synthroid and Acarodermatitis :

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Synthroid) and Synthroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.